Search

Your search keyword '"Meyohas, MC"' showing total 110 results

Search Constraints

Start Over You searched for: Author "Meyohas, MC" Remove constraint Author: "Meyohas, MC"
110 results on '"Meyohas, MC"'

Search Results

2. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

3. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

4. Lopinavir/Ritonavir Monotherapy as a Nucleoside Analogue–Sparing Strategy to Prevent HIV-1 Mother-to-Child Transmission: The ANRS 135 PRIMEVA Phase 2/3 Randomized Trial

5. Impact of Newly Available Drugs on Clinical Progression in Patients with Virological Failure after Exposure to Three Classes of Antiretrovirals

9. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

11. Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey)

12. Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus

13. Pulmonary cryptosporidiosis in the acquired immunodeficiency syndrome

14. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS

15. Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection

16. Persistent headaches one year after bacterial meningitis: prevalence, determinants and impact on quality of life.

17. Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV.

18. Prospective evaluation of blood Epstein-Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas.

19. Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV.

20. Expanding the spectrum of HIV-associated myopathy.

21. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.

22. Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.

23. First Report of CD4 Lymphopenia and Defective Neutrophil Functions in a Patient with Amebiasis Associated with CMV Reactivation and Severe Bacterial and Fungal Infections.

24. Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis.

25. High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.

26. Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum.

27. Splenic sarcoidosis: an unusual aetiology of agranulocytosis.

28. How to improve the quality of a disease management program for HIV-infected patients using a computerized data system. The Saint-Antoine Orchestra program.

29. Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient.

30. [Early diagnosis and prevention of comorbidities among HIV-infected patients: the Orchestra Saint-Antoine Program].

31. Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs.

32. Determinants of adherence to non-occupational post HIV exposure prophylaxis.

33. [Resolution of choreic movements associated with HIV encephalitis with anti-retroviral therapy].

34. [The use of microbiological tools for the diagnosis of nosocomial pulmonary infections].

35. Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough.

36. Major hypertriglyceridemia in HIV-infected patients on antiretroviral therapy: a role of the personal and family history.

37. Head and neck lesions in the immunocompromised host.

38. Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV-infected patients and their epidemiologic characteristics.

39. Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study.

40. Occurrence of acute hepatitis A in patients infected with human immunodeficiency virus.

41. Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators.

42. [Pseudotumoral abdominal granuloma concomitant with immune reconstitution after antiretroviral treatment].

43. [Severe immunoallergic reaction in a patient treated for two months continuously with rifampicin].

45. Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients.

46. [Brain imaging in AIDS].

47. [Paragonimiasis: a rare little known disease].

48. AIDS-related primary pulmonary lymphoma.

49. Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors.

50. Frequency and risk factors of infectious complications in neutropenic patients infected with HIV.

Catalog

Books, media, physical & digital resources